Traitement du déficit somatotrope chez l’adulte
暂无分享,去创建一个
[1] P. Chanson,et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. , 2004, The Journal of clinical endocrinology and metabolism.
[2] P. Saenger,et al. Growth hormone treatment and neoplasia-coincidence or consequence? , 2002, The Journal of clinical endocrinology and metabolism.
[3] R. Murray,et al. Adult growth hormone replacement: lessons learned and future direction. , 2002, The Journal of clinical endocrinology and metabolism.
[4] B. Conte-Devolx. Le diagnostic des déficits en hormone de croissance (GH) chez l'adulte , 2002 .
[5] G. Sassolas,et al. GH deficiency in adults: an epidemiological approach. , 1999, European journal of endocrinology.
[6] B. Conte-Devolx. Traitement par l'hormone de croissance chez l'adulte : Recommandations du club français de l'hypophyse , 1998 .
[7] B. Brennan,et al. The diagnosis of growth hormone deficiency in children and adults. , 1998, Endocrine reviews.
[8] E. Ghigo,et al. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. , 1998, The Journal of clinical endocrinology and metabolism.